Joe Betts-LaCroix, CEO of Sam Altman-backed longevity startup Retro Biosciences, joined DeSci Abu Dhabi as a surprise guest to discuss AI's growing influence on biomedical research:
"Biology is too hard for human scientists alone."
"There are around 20,000 human genes whose protein networks can generate on the order of 1M possible structural moieties. The best Harvard scientists specialize in only around 40."
Retro Biosciences recently worked with Open AI to create GPT-4b (b for "bio') aimed at uncovering biological insights and inventions which humans can't create on their own.
The model was used to uncover novel variants of the Yamanaka factors which achieve a 50x increase in reprogramming efficiency in vitro.
"The tools are here," Joe said. "Speed is the mantra. Regulatory infrastructure can slow things down, so we're looking to venues where people are innovating particularly on regulatory frameworks and human trials."
Exploring the next era of AI + biology, neuroscience, genetic engineering and longevity with speakers from Bio, @molecule_sci, @MIT, @EnhancedGames, @bnbchain, @Xtalpi & more!
Join us for a full day of talks and watch the live stream - https://x.com/BioProtocol/status/1998637762455765093?s=20
• Bio is expanding to @BNBCHAIN • @Aubrai_ BioAgent gets Deep Research • Biotech 2.0 workshop w/ @CompoundVC • DeSci Abu Dhabi • New framework for benchmarking Scientific AI
Read the full weekly update: https://x.com/BioProtocol/status/1997781828850119073
"The journey from an early conception to a drug being sold in pharmacies can take ten years or more and cost up to two billion dollars. DeSci is about bringing actual products to market far sooner."
@paulkhls at Binance Blockchain Week, moderated by @samikhojali from BNB Chain.
Hear from an award-winning MIT neuroscientist, an Olympian turned "enhanced" athlete, stem cell geneticists pushing boundaries in human regeneration and biotech investors shaking up science finance.
Hear from an award-winning MIT neuroscientist, an Olympian turned "enhanced" athlete, stem cell geneticists pushing boundaries in human regeneration and biotech investors shaking up science finance.
Live on stage TOMORROW ! at @binance Blockchain Week
Paul Kohlhass and Christian Angermayer will sit down for a fireside chat discussing how AI, biotech and crypto are converging to unlock new scientific breakthroughs and funding models.
You can now trade $BIO on BNB via @PancakeSwap, with more Bio ecosystem tokens being bridged in the coming weeks. BIO token on BNB: 0x226a2fa2556c48245e57cd1cba4c6c9e67077dd2 Stay tuned for upcoming launches on BNB
BIO Protocol
·
--
DeSci is coming to @BNBCHAIN 🧪
$BIO is now tradable on BNB, with more DeSci tokens coming.
This paves the way for Bio's Launchpad & x402-enabled BioAgents on BNB.
Bio is building a full-stack solution for DeSci builders and research communities to 100X the speed of science.
You can now trade $BIO on BNB via @PancakeSwap, with more Bio ecosystem tokens being bridged in the coming weeks.
BIO token on BNB: 0x226a2fa2556c48245e57cd1cba4c6c9e67077dd2
AI-driven biology is exploding, with giants like Google, OpenAI and Stanford University building scientific agents that read papers, generate hypotheses & design experiments.
But these tools remain siloed in Web2 - disconnected from capital, coordination & shared knowledge.
BioAgents break these barriers by integrating onchain features for data sharing, experiment funding & discovery monetization.
Experiments can start immediately once vetted, rather than languishing in traditional grant cycles, while BioAgents read and write to a decentralized knowledge graph integrated across the Bio network.
Stay tuned for more details on the first BioAgent launches, powered by $BIO